Platform
Publications & Presentations
An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections
June 23, 2023
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants
September 21, 2021
Induction of antigen-specific tolerance by nanobody–antigen adducts that target class-II major histocompatibility complexes
June 14, 2021